Condition

NUT Carcinoma

ClinicalTrials.gov condition label

Clinical trials3

Recruiting1

Common interventions3

Lead sponsors shown3

Clinical trials

3 shown

Biology of Young Lung Cancer Study: The YOUNG LUNG StudyNCT05265429 · 2023-01-01

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsNCT05812027 · 2023-06-26

ACTIVE_NOT_RECRUITING

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological MalignanciesNCT05488548 · 2022-12-21

Common interventions

Data and Specimen CollectionGENETIC1 EP31670DRUG1 Tumor and HLA ProfilingDIAGNOSTIC_TEST1

Leading sponsors

Dana-Farber Cancer Institute1 Epigenetix, Inc.1 TScan Therapeutics, Inc.1

Trial status mix

ACTIVE_NOT_RECRUITING1

RECRUITING1

UNKNOWN1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.